Copyright Reports & Markets. All rights reserved.

Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 CLIA
    • 1.4.3 ELISA
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2020 VS 2026
    • 1.5.2 Screening
    • 1.5.3 Post-treatment Monitoring
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2015-2026)
  • 2.2 Global Prostate-Specific Antigen (PSA) Test Growth Trends by Regions
    • 2.2.1 Prostate-Specific Antigen (PSA) Test Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prostate-Specific Antigen (PSA) Test Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prostate-Specific Antigen (PSA) Test Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Market Size
    • 3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
    • 3.2.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2019
  • 3.3 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
  • 3.4 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
  • 3.5 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)
  • 5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 6.2 Prostate-Specific Antigen (PSA) Test Key Players in North America (2019-2020)
  • 6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 7.2 Prostate-Specific Antigen (PSA) Test Key Players in Europe (2019-2020)
  • 7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

8 China

  • 8.1 China Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 8.2 Prostate-Specific Antigen (PSA) Test Key Players in China (2019-2020)
  • 8.3 China Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 8.4 China Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 9.2 Prostate-Specific Antigen (PSA) Test Key Players in Japan (2019-2020)
  • 9.3 Japan Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 9.4 Japan Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 10.2 Prostate-Specific Antigen (PSA) Test Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

11 India

  • 11.1 India Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 11.2 Prostate-Specific Antigen (PSA) Test Key Players in India (2019-2020)
  • 11.3 India Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 11.4 India Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prostate-Specific Antigen (PSA) Test Market Size (2015-2020)
  • 12.2 Prostate-Specific Antigen (PSA) Test Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Type (2015-2020)
  • 12.4 Central & South America Prostate-Specific Antigen (PSA) Test Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview
    • 13.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
    • 13.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Siemens Healthcare
    • 13.2.1 Siemens Healthcare Company Details
    • 13.2.2 Siemens Healthcare Business Overview
    • 13.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
    • 13.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.2.5 Siemens Healthcare Recent Development
  • 13.3 DiaSorin
    • 13.3.1 DiaSorin Company Details
    • 13.3.2 DiaSorin Business Overview
    • 13.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
    • 13.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.3.5 DiaSorin Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview
    • 13.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
    • 13.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Beckman Coulter
    • 13.5.1 Beckman Coulter Company Details
    • 13.5.2 Beckman Coulter Business Overview
    • 13.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
    • 13.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.5.5 Beckman Coulter Recent Development
  • 13.6 PerkinElmer
    • 13.6.1 PerkinElmer Company Details
    • 13.6.2 PerkinElmer Business Overview
    • 13.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
    • 13.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.6.5 PerkinElmer Recent Development
  • 13.7 Tosoh
    • 13.7.1 Tosoh Company Details
    • 13.7.2 Tosoh Business Overview
    • 13.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
    • 13.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.7.5 Tosoh Recent Development
  • 13.8 Ortho Clinical
    • 13.8.1 Ortho Clinical Company Details
    • 13.8.2 Ortho Clinical Business Overview
    • 13.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
    • 13.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.8.5 Ortho Clinical Recent Development
  • 13.9 Fujirebio
    • 13.9.1 Fujirebio Company Details
    • 13.9.2 Fujirebio Business Overview
    • 13.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
    • 13.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.9.5 Fujirebio Recent Development
  • 13.10 Mediwatch (LABORIE)
    • 13.10.1 Mediwatch (LABORIE) Company Details
    • 13.10.2 Mediwatch (LABORIE) Business Overview
    • 13.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
    • 13.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 13.10.5 Mediwatch (LABORIE) Recent Development
  • 13.11 BodiTech
    • 10.11.1 BodiTech Company Details
    • 10.11.2 BodiTech Business Overview
    • 10.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
    • 10.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2015-2020)
    • 10.11.5 BodiTech Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Prostate-Specific Antigen (PSA) Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-Specific Antigen (PSA) Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott
    Siemens Healthcare
    DiaSorin
    Roche
    Beckman Coulter
    PerkinElmer
    Tosoh
    Ortho Clinical
    Fujirebio
    Mediwatch (LABORIE)
    BodiTech

    Market segment by Type, the product can be split into
    CLIA
    ELISA
    Other
    Market segment by Application, split into
    Screening
    Post-treatment Monitoring
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now